Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 3
2011 1
2012 2
2013 2
2014 1
2015 3
2016 4
2017 4
2018 5
2019 7
2020 6
2021 5
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
In Silico Methods for Studying T Cell Biology.
Grzesik K, Eng K, Crauste F, Battaglia S. Grzesik K, et al. Among authors: battaglia s. Int Rev Cell Mol Biol. 2019;342:265-304. doi: 10.1016/bs.ircmb.2018.07.005. Epub 2018 Aug 16. Int Rev Cell Mol Biol. 2019. PMID: 30635092 Review.
Nature of tumour rejection antigens in ovarian cancer.
Want MY, Lugade AA, Battaglia S, Odunsi K. Want MY, et al. Among authors: battaglia s. Immunology. 2018 Oct;155(2):202-210. doi: 10.1111/imm.12951. Epub 2018 Jun 13. Immunology. 2018. PMID: 29772069 Free PMC article. Review.
Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials.
Vantourout P, Eum J, Conde Poole M, Hayday TS, Laing AG, Hussain K, Nuamah R, Kannambath S, Moisan J, Stoop A, Battaglia S, Servattalab R, Hsu J, Bayliffe A, Katragadda M, Hayday AC. Vantourout P, et al. Among authors: battaglia s. Sci Adv. 2023 Dec 8;9(49):eadj6174. doi: 10.1126/sciadv.adj6174. Epub 2023 Dec 6. Sci Adv. 2023. PMID: 38055824 Free PMC article.
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
Odunsi K, Qian F, Lugade AA, Yu H, Geller MA, Fling SP, Kaiser JC, Lacroix AM, D'Amico L, Ramchurren N, Morishima C, Disis ML, Dennis L, Danaher P, Warren S, Nguyen VA, Ravi S, Tsuji T, Rosario S, Zha W, Hutson A, Liu S, Lele S, Zsiros E, McGray AJR, Chiello J, Koya R, Chodon T, Morrison CD, Putluri V, Putluri N, Mager DE, Gunawan R, Cheever MA, Battaglia S, Matsuzaki J. Odunsi K, et al. Among authors: battaglia s. Sci Transl Med. 2022 Mar 16;14(636):eabg8402. doi: 10.1126/scitranslmed.abg8402. Epub 2022 Mar 16. Sci Transl Med. 2022. PMID: 35294258 Free PMC article.
WHSC1/NSD2 regulates immune infiltration in prostate cancer.
Want MY, Tsuji T, Singh PK, Thorne JL, Matsuzaki J, Karasik E, Gillard B, Cortes Gomez E, Koya RC, Lugade A, Odunsi K, Battaglia S. Want MY, et al. Among authors: battaglia s. J Immunother Cancer. 2021 Feb;9(2):e001374. doi: 10.1136/jitc-2020-001374. J Immunother Cancer. 2021. PMID: 33589522 Free PMC article.
42 results